These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 7909491

  • 1. Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer.
    Lukes AS, Kohler MF, Pieper CF, Kerns BJ, Bentley R, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast RC, Berchuck A.
    Cancer; 1994 May 01; 73(9):2380-5. PubMed ID: 7909491
    [Abstract] [Full Text] [Related]

  • 2. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 May 01; 17(2B):1417-23. PubMed ID: 9137508
    [Abstract] [Full Text] [Related]

  • 3. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O, el-Salahy E, Mahmoud M, Wahab MA, Eissa S, Khalifa A.
    Anticancer Res; 2002 May 01; 22(4):2493-9. PubMed ID: 12174951
    [Abstract] [Full Text] [Related]

  • 4. The relationship between mutant p53 gene, DNA contents and conventional clinicopathological prognostic variables in cases with endometrial carcinoma.
    Osmanağaoğlu MA, Kadioğlu S, Osmanağaoğlu S, Bozkaya H, Reis A, Tekelioğlu Y.
    Eur J Gynaecol Oncol; 2005 May 01; 26(1):64-70. PubMed ID: 15755004
    [Abstract] [Full Text] [Related]

  • 5. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 May 01; 17(4B):3091-7. PubMed ID: 9329609
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
    Nagai N, Oshita T, Fujii T, Kioka H, Katsube Y, Ohama K.
    Oncol Rep; 2000 May 01; 7(3):551-9. PubMed ID: 10767367
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prognostic importance of selected molecular genetic immunohistochemical markers and DNA ploidy in endometrial cancer].
    Kudela M, Pilka R, Lubuský M, Hejtmánek P, Dzubák P, Brychtová S.
    Ceska Gynekol; 2011 Jun 01; 76(3):194-9. PubMed ID: 21838149
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic indicators for neuroblastoma: stage, grade, DNA ploidy, MIB-1-proliferation index, p53, HER-2/neu and EGFr--a survival study.
    Layfield LJ, Thompson JK, Dodge RK, Kerns BJ.
    J Surg Oncol; 1995 May 01; 59(1):21-7. PubMed ID: 7745972
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.
    Bell JG, Minnick A, Reid GC, Judis J, Brownell M.
    Gynecol Oncol; 1997 Sep 01; 66(3):388-92. PubMed ID: 9299250
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
    Reinartz JJ, George E, Lindgren BR, Niehans GA.
    Hum Pathol; 1994 Oct 01; 25(10):1075-83. PubMed ID: 7927313
    [Abstract] [Full Text] [Related]

  • 19. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
    Hu WF, Liu MQ, Zhao Q.
    Ai Zheng; 2004 Sep 01; 23(9):1021-5. PubMed ID: 15363194
    [Abstract] [Full Text] [Related]

  • 20. Expression of Her-2/neu oncogene protein product and epidermal growth factor receptors in surgical specimens of human breast cancers.
    Moe RE, Moe KS, Porter P, Gown AM, Ellis G, Tapper D.
    Am J Surg; 1991 May 01; 161(5):580-3. PubMed ID: 1674411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.